Published in Immunol Rev on January 01, 1978
Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. J Exp Med (1979) 2.12
Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect Immun (1983) 1.97
Lymphocyte specificity to protein antigens. II. Fine specificity of T-cell activation with cytochrome c and derived peptides as antigenic probes. J Exp Med (1979) 1.73
Delayed-type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice. J Exp Med (1980) 1.54
A cloned cell line mediating natural killer cell function inhibits immunoglobulin secretion. J Exp Med (1982) 1.41
The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology (1986) 1.33
Induction and mode of action of suppressor cells generated against human gamma globulin. I. An immunologic unresponsive state devoid of demonstrable suppressor cells. J Exp Med (1978) 1.29
Regulatory mechanisms in immune responses to heterologous insulins. II. Suppressor T cell activation associated with nonresponsiveness in H-2b mice. J Exp Med (1984) 1.12
Autoimmune diseases: immunopathology and etiopathogenesis. Am J Pathol (1982) 1.07
Anti-thyroglobulin autoantibodies in sera from patients with chronic thyroiditis and from healthy subjects: differences in cross-reactivity with thyroid peroxidase. Clin Exp Immunol (1990) 0.93
Anti-erythrocyte autoantibody production in mice associated with the injection of rat erythrocytes. Immunology (1980) 0.92
Regulation of IgG memory responses by helper and suppressor T cells activated by the type 2 antigen, polyvinylpyrrolidone. J Exp Med (1985) 0.91
Specific suppression of allograft rejection by trinitrophenyl (TNP)-induced suppressor cells in recipients treated with TNP-haptenated donor alloantigens. J Exp Med (1985) 0.88
Production of antigen-specific suppressive T cell factor by radiation leukemia virus-transformed suppressor T cells. Proc Natl Acad Sci U S A (1981) 0.86
Acceptor-suppressor T cell hybridoma with a receptor recognizing antigen-specific suppressor factor. J Exp Med (1983) 0.83
Inhibition of lymphocyte proliferation by free fatty acids. III. Modulation of thymus-dependent immune responses. Immunology (1985) 0.82
Immune response genes have a variable influence on the selection of antigenic foreign and self determinants of insulin. Proc Natl Acad Sci U S A (1979) 0.79
Use of anti-idiotype immunosorbents to isolate circulating antigen-specific T cell-derived molecules from hyperimmune sera. Proc Natl Acad Sci U S A (1983) 0.78
Positive selection of major histocompatibility complex-restricted suppressor T cells bearing the predominant idiotype in the immune response to lysozyme. Proc Natl Acad Sci U S A (1981) 0.78
Special regulatory T-cell review: T-cell dependent suppression revisited. Immunology (2008) 0.77
The involvement of suppressor T cells in Ir gene regulation of secondary antibody responses of primed (responder X nonresponder)F1 mice to macrophage-bound L-glutamic acid60-L-alanine30-L-tyrosine. J Exp Med (1978) 0.75
Characterization of rat spleen cell populations. II. Activation by antigens and allogeneic cells. Immunology (1980) 0.75
Premises for immune interventional therapy in rheumatoid arthritis. Postgrad Med J (1988) 0.75
Unconventional T-cell recognition of an arthritogenic epitope of proteoglycan aggrecan released from degrading cartilage. Immunology (2015) 0.75
Differential major histocompatibility complex-related activation of idiotypic suppressor T cells. Suppressor T cells cross-reactive to two distantly related lysozymes are not induced by one of them. J Exp Med (1980) 0.75
A physical map of the human genome. Nature (2001) 12.39
Chlamydial infection. Isolation of Chlamydia from patients with non-specific genital infection. Br J Vener Dis (1972) 7.92
E-cadherin germline mutations in familial gastric cancer. Nature (1998) 6.72
Mechanisms of lactose utilization by lactic acid streptococci: enzymatic and genetic analyses. J Bacteriol (1970) 6.34
Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev (2000) 5.80
The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol (1998) 5.50
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature (1992) 5.47
Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (1993) 5.47
The antigenic structure of proteins: a reappraisal. Annu Rev Immunol (1984) 5.31
Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell (1988) 4.47
Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol (1993) 4.23
Rapid diagnosis of pulmonary tuberculosis by using Roche AMPLICOR Mycobacterium tuberculosis PCR test. J Clin Microbiol (1995) 4.11
Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol (1994) 4.07
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med (1997) 4.04
1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol (2000) 3.82
Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET. J Cogn Neurosci (2000) 3.66
Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today (1993) 3.62
Chlamydial infections of the cervix. Br J Vener Dis (1974) 3.48
IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol (1998) 3.37
Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke (1997) 3.26
Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol (2007) 3.24
Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med (1990) 2.97
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology (1995) 2.90
Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis (1983) 2.83
Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol (2001) 2.75
Surgical complication outcome (SCOUT) score: a new method to evaluate quality of care in vascular surgery. J Vasc Surg (1997) 2.67
Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med (1990) 2.58
The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site. Immunol Rev (1987) 2.56
Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis (2001) 2.51
Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J Exp Med (1987) 2.42
Suppression of antibody and T cell proliferative responses to L-glutamic acid60-L-alanine30-L-tyrosine10 by a specific monoclonal T cell factor. J Exp Med (1980) 2.41
Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem (2000) 2.37
Cell wall and protoplast isoperoxidases in relation to injury, indoleacetic Acid, and ethylene effects. Plant Physiol (1974) 2.36
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology (2012) 2.34
Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med (1995) 2.29
Quasi-hexagonal molecular packing in collagen fibrils. Nature (1980) 2.28
Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol (1984) 2.25
Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognition. Immunol Today (1989) 2.23
Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol (1989) 2.22
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med (1987) 2.21
The X-Y-Z scheme of immunocyte maturation. 3. Early IgM memory and the nature of the memory cell. J Immunol (1967) 2.16
Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. J Exp Med (1979) 2.12
Phonons and the elastic moduli of collagen and muscle. Nature (1977) 2.09
Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. J Consult Clin Psychol (2001) 1.99
The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann N Y Acad Sci (1974) 1.99
Determination of the elastic constants of collagen by Brillouin light scattering. J Mol Biol (1979) 1.97
Changes in pulmonary function in workers exposed to vinyl chloride and polyvinyl chloride. Ann N Y Acad Sci (1975) 1.95
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol (1996) 1.92
Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant (1990) 1.91
Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry (2005) 1.91
The asynchronous development of immunological memory in helper (T) and precursor (B) cell lines. Eur J Immunol (1971) 1.91
Mean and instantaneous expiratory flows, FVC and FEV1: prediction equations from a probability sample of Michigan, a large industrial state. Bull Eur Physiopathol Respir (1987) 1.88
Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol (2001) 1.82
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J Exp Med (1993) 1.80
Monocular elevation weakness and ptosis: an oculomotor fascicular syndrome? J Clin Neuroophthalmol (1991) 1.78
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today (2000) 1.77
Audit of emergency preoperative resuscitation. Br J Surg (1994) 1.73
Volatile compounds produced in sterile fish muscle (Sebastes melanops) by Pseudomonas perolens. Appl Microbiol (1973) 1.73
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest (1993) 1.73
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol (1997) 1.72
Structure of insect fibrillar flight muscle in the presence and absence of ATP. J Mol Biol (1972) 1.70
Analysis of the primary structure of collagen for the origins of molecular packing. J Mol Biol (1973) 1.68
Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol (1989) 1.68
Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med (1999) 1.68
The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol (1998) 1.65
Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J Exp Med (1989) 1.65
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer. Br J Cancer (2011) 1.65
Interpretation of the meridional X-ray diffraction pattern from collagen fibres in terms of the known amino acid sequence. J Mol Biol (1977) 1.64
Capacity of intact proteins to bind to MHC class II molecules. J Immunol (1989) 1.63
Molecular conformation and packing in collagen fibrils. J Mol Biol (1983) 1.62
Epitope specificity of the T cell proliferative response to lysozyme: proliferative T cells react predominantly to different determinants from those recognized by B cells. Eur J Immunol (1980) 1.62
Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice. J Exp Med (1996) 1.61
Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J Immunol (1987) 1.60
Asbestos exposure of brake repair workers in the United States. Mt Sinai J Med (1976) 1.59
Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med (1999) 1.58
Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J Exp Med (1996) 1.58
Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. J Immunol (1993) 1.57
Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients. Ann Neurol (2001) 1.55
The Ontario Mental Health Act, 1978. A comment on its application. Can J Psychiatry (1979) 1.55
A randomised comparison of SurePath liquid-based cytology and conventional smear cytology in a colposcopy clinic setting. BJOG (2008) 1.55
Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed) (1983) 1.55
Induction of anti-self-immunity to cure cancer. Cell (1995) 1.54
The control of T cell responses by dendritic cell subsets. Curr Opin Immunol (2000) 1.53
Interaction of asbestos, age, and cigarette smoking in producing radiographic evidence of diffuse pulmonary fibrosis. Am J Med (1986) 1.53
The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today (1995) 1.51
The in situ supermolecular structure of type I collagen. Structure (2001) 1.50
Molecular packing in type I collagen fibrils. J Mol Biol (1987) 1.49
The closing of a social HMO: a case study. J Aging Soc Policy (1998) 1.49
A review of water quality concerns in livestock farming areas. Sci Total Environ (2000) 1.48
Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation. Nature (1986) 1.47
T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes. J Exp Med (1991) 1.47
Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med (1992) 1.46
Purification and characterization of a monoclonal T-cell suppressor factor specific for poly(LGlu60LAla30LTyr10). Proc Natl Acad Sci U S A (1982) 1.46
Pulmonary diffusing capacity in left ventricular dysfunction. Chest (1990) 1.46
Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. J Exp Med (1997) 1.45